Free Trial

Hsbc Holdings PLC Has $14.25 Million Holdings in Bath & Body Works, Inc. $BBWI

Bath & Body Works logo with Retail/Wholesale background

Key Points

  • Hsbc Holdings PLC increased its stake in Bath & Body Works by 64.9% in the first quarter, now owning 470,478 shares valued at approximately $14.25 million.
  • The stock, currently trading at around $31.05, has a consensus analyst rating of "Moderate Buy" with an average target price of $42.06.
  • Bath & Body Works announced a quarterly dividend of $0.20 per share, translating to an annual yield of 2.6% with a payout ratio of 21.33%.
  • Looking to export and analyze Bath & Body Works data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Hsbc Holdings PLC boosted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 64.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 470,478 shares of the company's stock after purchasing an additional 185,221 shares during the quarter. Hsbc Holdings PLC owned 0.22% of Bath & Body Works worth $14,251,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Victory Capital Management Inc. lifted its stake in Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after buying an additional 6,752,274 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company's stock valued at $111,581,000 after buying an additional 1,973,679 shares in the last quarter. Northern Trust Corp lifted its stake in Bath & Body Works by 12.7% in the first quarter. Northern Trust Corp now owns 2,389,781 shares of the company's stock valued at $72,458,000 after buying an additional 269,508 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Bath & Body Works by 9.8% in the first quarter. Bank of New York Mellon Corp now owns 2,274,388 shares of the company's stock valued at $68,959,000 after buying an additional 203,724 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Bath & Body Works by 17.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,144,292 shares of the company's stock valued at $83,135,000 after buying an additional 313,092 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Trading Down 6.6%

Shares of NYSE:BBWI traded down $2.08 on Thursday, hitting $29.47. The company had a trading volume of 17,266,529 shares, compared to its average volume of 5,192,912. Bath & Body Works, Inc. has a 1-year low of $24.94 and a 1-year high of $41.87. The stock has a market cap of $6.24 billion, a price-to-earnings ratio of 7.86, a P/E/G ratio of 1.05 and a beta of 1.54. The stock has a 50 day moving average price of $30.58 and a 200 day moving average price of $30.90.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the company earned $0.37 earnings per share. The company's quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be paid a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.7%. Bath & Body Works's dividend payout ratio is 21.33%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on BBWI. The Goldman Sachs Group cut their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, May 30th. Morgan Stanley cut their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 6th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Telsey Advisory Group reissued an "outperform" rating and issued a $38.00 price objective on shares of Bath & Body Works in a research report on Thursday. Finally, Barclays cut their price objective on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research report on Friday, May 30th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $42.53.

Check Out Our Latest Report on BBWI

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Stories

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines